SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-165250
Filing Date
2022-06-01
Accepted
2022-06-01 16:36:05
Documents
14
Period of Report
2022-05-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d335153d8k.htm   iXBRL 8-K 42842
2 EX-99.1 d335153dex991.htm EX-99.1 9700
6 GRAPHIC g335153g0531233200080.jpg GRAPHIC 3726
  Complete submission text file 0001193125-22-165250.txt   183127

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20220526.xsd EX-101.SCH 2872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20220526_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20220526_pre.xml EX-101.PRE 10823
8 EXTRACTED XBRL INSTANCE DOCUMENT d335153d8k_htm.xml XML 3225
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 22987895
SIC: 2834 Pharmaceutical Preparations